Bard buys ultrasound manufacturer Dymax:
This article was originally published in Clinica
Executive Summary
CR Bard has bought privately-owned Dymax for an undisclosed sum. The transaction will bring Bard the Site-Right II, a small, battery-operated, portable ultrasound system which is used to guide needles for percutaneous vascular access. The device enables the surgeon to see the vessel, observe the needle puncture and place a line with fewer attempts. Bard will also get Dymax' TM18 ultrasound scanners, probes, needle guides and other accessories. The product line will be sold through Bard's Salt Lake City, Utah-based access systems subsidiary.